MEDIUM confidence: 100% data completeness, but the composite (48) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $59.2B— | $67.2B+13.7% | $59.5B-11.4% | $53.1B-10.8% | $70.3B+32.4% |
| EPS (dil.) | $13.64— | $10.51-22.9% | $14.87+41.5% | $7.99-46.3% | $4.92-38.4% |
| Free Cash Flow | -$3.3B— | -$6.1Bn/m | $2.2Bn/m | $524M-76.0% | -$879M-267.7% |
| Gross Margin | 5.7% | 5.5%-0.2pp | 8.1%+2.7pp | 6.4%-1.7pp | 4.8%-1.5pp |
| Operating Margin | 3.6% | 3.4%-0.2pp | 5.3%+1.8pp | 3.0%-2.2pp | 1.8%-1.2pp |
| Net Margin | 3.5% | 2.4%-1.1pp | 3.8%+1.4pp | 2.1%-1.6pp | 1.2%-1.0pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Buy-rated share 89% → 89% over ~3 months (+0pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $1.97 | $2.00 | +1.5% |
| Apr 2026 | $0.88 | $1.83 | +107.2% |
| Feb 2026 | $1.81 | $1.99 | +9.9% |
| Nov 2025 | $1.94 | $2.27 | +17.0% |
| Jul 2025 | $1.09 | $1.31 | +20.2% |
| May 2025 | $1.28 | $1.81 | +41.4% |
| Feb 2025 | $2.30 | $2.13 | -7.4% |
| Oct 2024 | $2.14 | $2.29 | +7.0% |
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth below the analyst consensus of 15.6%/yr (revenue basis).
Base free cash flow $610M (avg FY2023–FY2025; latest year -$879M) · equity value $21.8B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Net insider $689K over 180 days (2 open-market buys, 0 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
The QScore of 48 for BG indicates a neutral outlook, driven by mixed category scores. The stock scores high on value, with a P/E of 22.0 and P/B of 1.4, as well as growth and momentum, exhibiting strong revenue growth of 32.4% and a 12-month return of 37.8%. However, profitability is a concern, with a low ROE of 6.3% and negative FCF yield, dragging the overall score down. The long-term and short-term scores are relatively aligned, with only a 3-point difference.